Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke
BJU International, 03/18/2010
Hayes JH et al. – The use of short–course AST in men with a history of MI or stroke is associated with a greater risk of ACM in men with favourable–risk prostate cancer.







